Mercer Global Advisors
TMO icon

Mercer Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Mercer Global Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Buy
51,463
+14,748
+40% +$7.08M 0.03% 299
2026
Q1 		$18M Sell
36,715
-2,188
-6% -$1.19M 0.03% 342
2025
Q4 		$22.5M Buy
38,903
+4,697
+14% +$2.66M 0.03% 310
2025
Q3 		$16.6M Buy
34,206
+3,970
+13% +$1.85M 0.03% 358
2025
Q2 		$12.3M Buy
30,236
+4,428
+17% +$1.85M 0.03% 341
2025
Q1 		$12.8M Buy
25,808
+1,272
+5% +$689K 0.03% 306
2024
Q4 		$12.8M Sell
24,536
-13,867
-36% -$7.62M 0.03% 304
2024
Q3 		$23.5M Buy
38,403
+2,936
+8% +$1.74M 0.06% 192
2024
Q2 		$19.5M Buy
35,467
+9,656
+37% +$5.53M 0.05% 198
2024
Q1 		$15.1M Buy
25,811
+834
+3% +$468K 0.04% 235
2023
Q4 		$13.3M Buy
24,977
+1,706
+7% +$826K 0.04% 253
2023
Q3 		$11.8M Sell
23,271
-4,235
-15% -$2.26M 0.04% 241
2023
Q2 		$14.4M Sell
27,506
-1,064
-4% -$574K 0.06% 218
2023
Q1 		$16.5M Sell
28,570
-390
-1% -$220K 0.07% 188
2022
Q4 		$15.9M Sell
28,960
-5,755
-17% -$3.05M 0.08% 187
2022
Q3 		$17.6M Sell
34,715
-2,980
-8% -$1.67M 0.1% 152
2022
Q2 		$20.5M Sell
37,695
-1,130
-3% -$622K 0.13% 130
2022
Q1 		$22.9M Buy
38,825
+3,598
+10% +$2.07M 0.14% 120
2021
Q4 		$23.5M Buy
35,227
+3,091
+10% +$1.93M 0.15% 109
2021
Q3 		$18.4M Buy
32,136
+1,383
+4% +$759K 0.13% 138
2021
Q2 		$15.5M Buy
30,753
+3,405
+12% +$1.61M 0.12% 134
2021
Q1 		$12.5M Buy
27,348
+6,873
+34% +$3.28M 0.11% 143
2020
Q4 		$9.54M Buy
20,475
+761
+4% +$357K 0.12% 129
2020
Q3 		$8.7M Sell
19,714
-3,564
-15% -$1.47M 0.13% 121
2020
Q2 		$8.43M Sell
23,278
-570
-2% -$191K 0.15% 97
2020
Q1 		$6.76M Buy
23,848
+5,622
+31% +$1.77M 0.15% 119
2019
Q4 		$5.92M Buy
18,226
+1,281
+8% +$388K 0.12% 153
2019
Q3 		$4.93M Buy
16,945
+370
+2% +$106K 0.12% 152
2019
Q2 		$4.87M Buy
16,575
+52
+0.3% +$14.3K 0.13% 140
2019
Q1 		$4.52M Buy
+16,523
New +$4.11M 0.16% 117

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mercer Global Advisors's TMO Position: Q2 2026 in Review

Mercer Global Advisors increased its Thermo Fisher Scientific (TMO) stake by 40% in Q2 2026, buying an estimated $7.08M and bringing the position to 51,463 shares worth $25.8M. The position accounts for 0.03% of the portfolio, ranked #299.

Mercer Global Advisors first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mercer Global Advisors held 51,463 shares of Thermo Fisher Scientific worth $25.8M as of Q2 2026.
  • Mercer Global Advisors bought 14,748 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.08M.
  • Thermo Fisher Scientific made up 0.03% of Mercer Global Advisors's portfolio in Q2 2026, its #299 holding.
  • Mercer Global Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.